SOURCE: Revolutions Medical Corporation

Revolutions Medical Corporation Logo

May 21, 2013 08:59 ET

Revolutions Medical Receives Contract for 12 Million RevVac™ Safety Syringes From Its Brazilian Distributor

CHARLESTON, SC--(Marketwired - May 21, 2013) - Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB: RMCP) has received a 12 million unit contract of its RevVac™ auto-retractable vacuum safety syringe from AGN Tech International, LLC, ("AGN Tech") the exclusive distributor of all RevVac™ safety syringe product lines in Brazil. The contract is for 1 million units per month for a twelve month term.

Chief Executive Officer and Chairman, Ron Wheet, stated, "I am very pleased with the results in Brazil to date and the efforts of our distributor, AGN Tech. AGN Tech has done exceptional work introducing the RevVac™ safety syringes to the Brazilian marketplace. We expect continued success from this market going forward."

Carlos Carvalho, President of AGN Tech, commented, "The RevVac™ safety syringes provide quality and value to the expanding Brazilian marketplace. I feel we can continue to capture market share with all the positive benefits the RevVac™ product has to offer."

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its proprietary technologies and products include: the RevVac™ safety syringe, safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS) and prefilled auto-retraction vacuum safety syringes.

For additional information, please visit Revolutions Medical corporate website:
http://www.revolutionsmedical.com/

To be added to the Revolutions Medical investor email list, please email:
investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information

  • CONTACT:

    Revolutions Medical Corporation
    Investor Relations
    Tel.: (843) 606-9461
    4820-6932-2772, v. 1